141 related articles for article (PubMed ID: 6814009)
1. Strong association between an HLA-DR antigen and thyroid carcinoma.
Panza N; Del Vecchio L; Maio M; De Felice M; Lombardi G; Minozzi M; Zappacosta S
Tissue Antigens; 1982 Aug; 20(2):155-8. PubMed ID: 6814009
[TBL] [Abstract][Full Text] [Related]
2. [HLA and thyroid cancer].
Dralle H; Robin-Winn M; Reilmann L; Laue A; Török M
Klin Wochenschr; 1986 Jun; 64(11):522-5. PubMed ID: 3459939
[TBL] [Abstract][Full Text] [Related]
3. Lack of association of HLA with thyroid cancer. An effect of iodine sufficiency and safe environment?
Larsen B; Thompson C; Kwan A; Farid NR
Tissue Antigens; 1986 Nov; 28(5):298-300. PubMed ID: 3824363
[TBL] [Abstract][Full Text] [Related]
4. Association of differentiated thyroid carcinoma with HLA-DR7.
Sridama V; Hara Y; Fauchet R; DeGroot LJ
Cancer; 1985 Sep; 56(5):1086-8. PubMed ID: 3874685
[TBL] [Abstract][Full Text] [Related]
5. Significance of the expression of major histocompatibility complex class II antigen, HLA-DR and -DQ, with recurrence of papillary thyroid cancer.
Jo YS; Lee JC; Li S; Choi YS; Bai YS; Kim YJ; Lee IS; Rha SY; Ro HK; Kim JM; Shong M
Int J Cancer; 2008 Feb; 122(4):785-90. PubMed ID: 17957790
[TBL] [Abstract][Full Text] [Related]
6. Immunogenetic and immunologic studies of differentiated thyroid cancer.
Juhasz F; Boros P; Szegedi G; Balazs G; Suranyi P; Kraszits E; Stenszky V; Farid NR
Cancer; 1989 Apr; 63(7):1318-26. PubMed ID: 2784072
[TBL] [Abstract][Full Text] [Related]
7. Familial occurrence of differentiated, nonmedullary thyroid carcinoma.
Ozaki O; Ito K; Kobayashi K; Suzuki A; Manabe Y; Hosoda Y
World J Surg; 1988 Aug; 12(4):565-71. PubMed ID: 3048001
[No Abstract] [Full Text] [Related]
8. Well differentiated thyroid carcinoma is associated with human lymphocyte antigen D-related 11 in Eastern Hungarians: a case of changing circumstances.
Juhasz F; Kozma L; Stenszky V; Gyory F; Luckas G; Farid NR
Cancer; 2005 Oct; 104(8):1603-8. PubMed ID: 16121403
[TBL] [Abstract][Full Text] [Related]
9. New evidence for the existence of HLA-B14 subtypes. Linkage with different DR antigens.
Mueller-Eckhardt G; Mayr WR; Prel L; Mueller-Eckhardt C
Tissue Antigens; 1983 Jan; 21(1):58-61. PubMed ID: 6404003
[TBL] [Abstract][Full Text] [Related]
10. HLA-DR alpha gene regulation in immortalized human thyroid cancer cells.
Neufeld DS; Lahat N; Graves P; Gillon-Peled M; Kraiem Z; Davies TF
Clin Immunol Immunopathol; 1993 May; 67(2):151-6. PubMed ID: 8519090
[TBL] [Abstract][Full Text] [Related]
11. Histocompatibility antigens in polymyalgia rheumatica and giant cell arteritis.
Armstrong RD; Behn A; Myles A; Panayi GS; Welsh KI
J Rheumatol; 1983 Aug; 10(4):659-61. PubMed ID: 6413689
[TBL] [Abstract][Full Text] [Related]
12. Mixed lymphocyte reactions for individuals with phenotypic identity for specific HLA-B,DR determinants: the role of linkage disequilibrium and of specific DR and other class II determinants.
Pollack MS; Chin-Louie J; Callaway C; Blanco MA; Slavin K; Sullivan K; O'Reilly RJ; Dupont B
J Clin Immunol; 1983 Oct; 3(4):341-51. PubMed ID: 6197424
[TBL] [Abstract][Full Text] [Related]
13. Major histocompatibility restriction of antigen recognition by T cells in a recipient of haplotype mismatched human bone marrow transplantation.
Chu E; Umetsu D; Rosen F; Geha RS
J Clin Invest; 1983 Sep; 72(3):1124-9. PubMed ID: 6193142
[TBL] [Abstract][Full Text] [Related]
14. HLA antigen associations in hypertrophic cardiomyopathy.
Mourant AJ; Kafetz KM; Brigden WW; Awad J; D'Amaro J; Yeatman NW; Festenstein H
Tissue Antigens; 1982 Nov; 20(5):389-93. PubMed ID: 6818713
[TBL] [Abstract][Full Text] [Related]
15. HLA and thyroid carcinoma.
Ahuja S; Hoppe I; von Keyserlingk H; Ernst H
Exp Clin Endocrinol; 1992; 99(3):134-6. PubMed ID: 1526261
[TBL] [Abstract][Full Text] [Related]
16. Histocompatibility. Influence of HLA-DR matching on renal graft survival. A Scandiatransplant report.
Moen T; Berger L; Goyer K; Dahl O; Thorsby E
Scand J Urol Nephrol Suppl; 1981; 64():30-7. PubMed ID: 6815792
[No Abstract] [Full Text] [Related]
17. HLA-DR association in papillary thyroid carcinoma.
Amoli MM; Yazdani N; Amiri P; Sayahzadeh F; Haghpanah V; Tavangar SM; Amirzargar A; Ghaffari H; Nikbin B; Larijani B; Mostaan LV; Bazzaz JT
Dis Markers; 2010; 28(1):49-53. PubMed ID: 20164547
[TBL] [Abstract][Full Text] [Related]
18. Human leukocyte antigen associations in basal cell carcinoma.
Myskowski PL; Pollack MS; Schorr E; Dupont B; Safai B
J Am Acad Dermatol; 1985 Jun; 12(6):997-1000. PubMed ID: 3874217
[TBL] [Abstract][Full Text] [Related]
19. Important of HLA matching in cadaveric renal transplantation. A prospective one-center study.
Moen T; Flatmark A; Jervell J; Dahl O; Halvorsen S; Solheim B; Thorsby E
Scand J Urol Nephrol Suppl; 1981; 64():64-71. PubMed ID: 6815795
[TBL] [Abstract][Full Text] [Related]
20. HLA and B-lymphocyte alloantigens in Gila River Indians.
Ensroth AF; Mann DL; Johnson AH; Knowler WC; Pettitt DJ; Bennett PH
Tissue Antigens; 1983 Mar; 21(3):198-207. PubMed ID: 6407143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
